CMS Reimbursement Change For Hyaluronic Acid-Based Viscosupplement Products
Fidia is committed to compliantly assisting our customers to ensure a smooth transition from WAC-based to ASP-based reimbursement. The ASP file, the basis for setting reimbursement, becomes effective July 1, 2022. Read the full communication sent to customers of Fidia Pharma USA Inc. and learn how to contact us for more information and assistance.